Report Detail
Global Endometriosis Market Insights, Forecast to 2025
- RnM2734229 |
- 21 July, 2020 |
- Global |
- 153 Pages |
- QYResearch |
- Pharma & Healthcare
Endometriosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Endometriosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Endometriosis market is segmented into
Gonadotropins Releasing Hormone Agonists
Non-Steroidal Anti-Inflammatory Drugs
Progestin
Oral Contraceptive Pills
Segment by Application, the Endometriosis market is segmented into
Hospital Use
Clinic Use
Other
Regional and Country-level Analysis
The Endometriosis market is analysed and market size information is provided by regions (countries).
The key regions covered in the Endometriosis market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Endometriosis Market Share Analysis
Endometriosis market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Endometriosis business, the date to enter into the Endometriosis market, Endometriosis product introduction, recent developments, etc.
The major vendors covered:
AbbVie
AstraZeneca
Bayer HealthCare
Pfizer
Addex Therapeutics
Astellas Pharma
Debiopharm
ElexoPharm
EndoCeutics
Euroscreen
Forendo Pharma
Kissei Pharmaceutical
Neurocrine Biosciences
Nippon Shinyaku
Takeda
Bayer AG
Neurocrine Biosciences
1 Study Coverage
- 1.1 Endometriosis Product Introduction
- 1.2 Market Segments
- 1.3 Key Endometriosis Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Endometriosis Market Size Growth Rate by Type
- 1.4.2 Gonadotropins Releasing Hormone Agonists
- 1.4.3 Non-Steroidal Anti-Inflammatory Drugs
- 1.4.4 Progestin
- 1.4.5 Oral Contraceptive Pills
- 1.5 Market by Application
- 1.5.1 Global Endometriosis Market Size Growth Rate by Application
- 1.5.2 Hospital Use
- 1.5.3 Clinic Use
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Endometriosis Market Size, Estimates and Forecasts
- 2.1.1 Global Endometriosis Revenue 2015-2026
- 2.1.2 Global Endometriosis Sales 2015-2026
- 2.2 Global Endometriosis, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Endometriosis Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Endometriosis Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Endometriosis Competitor Landscape by Players
- 3.1 Endometriosis Sales by Manufacturers
- 3.1.1 Endometriosis Sales by Manufacturers (2015-2020)
- 3.1.2 Endometriosis Sales Market Share by Manufacturers (2015-2020)
- 3.2 Endometriosis Revenue by Manufacturers
- 3.2.1 Endometriosis Revenue by Manufacturers (2015-2020)
- 3.2.2 Endometriosis Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Endometriosis Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Endometriosis Revenue in 2019
- 3.2.5 Global Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Endometriosis Price by Manufacturers
- 3.4 Endometriosis Manufacturing Base Distribution, Product Types
- 3.4.1 Endometriosis Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Endometriosis Product Type
- 3.4.3 Date of International Manufacturers Enter into Endometriosis Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Endometriosis Market Size by Type (2015-2020)
- 4.1.1 Global Endometriosis Sales by Type (2015-2020)
- 4.1.2 Global Endometriosis Revenue by Type (2015-2020)
- 4.1.3 Endometriosis Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Endometriosis Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Endometriosis Sales Forecast by Type (2021-2026)
- 4.2.2 Global Endometriosis Revenue Forecast by Type (2021-2026)
- 4.2.3 Endometriosis Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Endometriosis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Endometriosis Market Size by Application (2015-2020)
- 5.1.1 Global Endometriosis Sales by Application (2015-2020)
- 5.1.2 Global Endometriosis Revenue by Application (2015-2020)
- 5.1.3 Endometriosis Price by Application (2015-2020)
- 5.2 Endometriosis Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Endometriosis Sales Forecast by Application (2021-2026)
- 5.2.2 Global Endometriosis Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Endometriosis Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Endometriosis by Country
- 6.1.1 North America Endometriosis Sales by Country
- 6.1.2 North America Endometriosis Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Endometriosis Market Facts & Figures by Type
- 6.3 North America Endometriosis Market Facts & Figures by Application
7 Europe
- 7.1 Europe Endometriosis by Country
- 7.1.1 Europe Endometriosis Sales by Country
- 7.1.2 Europe Endometriosis Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Endometriosis Market Facts & Figures by Type
- 7.3 Europe Endometriosis Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Endometriosis by Region
- 8.1.1 Asia Pacific Endometriosis Sales by Region
- 8.1.2 Asia Pacific Endometriosis Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Endometriosis Market Facts & Figures by Type
- 8.3 Asia Pacific Endometriosis Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Endometriosis by Country
- 9.1.1 Latin America Endometriosis Sales by Country
- 9.1.2 Latin America Endometriosis Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Endometriosis Market Facts & Figures by Type
- 9.3 Central & South America Endometriosis Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Endometriosis by Country
- 10.1.1 Middle East and Africa Endometriosis Sales by Country
- 10.1.2 Middle East and Africa Endometriosis Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Endometriosis Market Facts & Figures by Type
- 10.3 Middle East and Africa Endometriosis Market Facts & Figures by Application
11 Company Profiles
- 11.1 AbbVie
- 11.1.1 AbbVie Corporation Information
- 11.1.2 AbbVie Description and Business Overview
- 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AbbVie Endometriosis Products Offered
- 11.1.5 AbbVie Related Developments
- 11.2 AstraZeneca
- 11.2.1 AstraZeneca Corporation Information
- 11.2.2 AstraZeneca Description and Business Overview
- 11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 AstraZeneca Endometriosis Products Offered
- 11.2.5 AstraZeneca Related Developments
- 11.3 Bayer HealthCare
- 11.3.1 Bayer HealthCare Corporation Information
- 11.3.2 Bayer HealthCare Description and Business Overview
- 11.3.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Bayer HealthCare Endometriosis Products Offered
- 11.3.5 Bayer HealthCare Related Developments
- 11.4 Pfizer
- 11.4.1 Pfizer Corporation Information
- 11.4.2 Pfizer Description and Business Overview
- 11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Pfizer Endometriosis Products Offered
- 11.4.5 Pfizer Related Developments
- 11.5 Addex Therapeutics
- 11.5.1 Addex Therapeutics Corporation Information
- 11.5.2 Addex Therapeutics Description and Business Overview
- 11.5.3 Addex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Addex Therapeutics Endometriosis Products Offered
- 11.5.5 Addex Therapeutics Related Developments
- 11.6 Astellas Pharma
- 11.6.1 Astellas Pharma Corporation Information
- 11.6.2 Astellas Pharma Description and Business Overview
- 11.6.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Astellas Pharma Endometriosis Products Offered
- 11.6.5 Astellas Pharma Related Developments
- 11.7 Debiopharm
- 11.7.1 Debiopharm Corporation Information
- 11.7.2 Debiopharm Description and Business Overview
- 11.7.3 Debiopharm Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Debiopharm Endometriosis Products Offered
- 11.7.5 Debiopharm Related Developments
- 11.8 ElexoPharm
- 11.8.1 ElexoPharm Corporation Information
- 11.8.2 ElexoPharm Description and Business Overview
- 11.8.3 ElexoPharm Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 ElexoPharm Endometriosis Products Offered
- 11.8.5 ElexoPharm Related Developments
- 11.9 EndoCeutics
- 11.9.1 EndoCeutics Corporation Information
- 11.9.2 EndoCeutics Description and Business Overview
- 11.9.3 EndoCeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 EndoCeutics Endometriosis Products Offered
- 11.9.5 EndoCeutics Related Developments
- 11.10 Euroscreen
- 11.10.1 Euroscreen Corporation Information
- 11.10.2 Euroscreen Description and Business Overview
- 11.10.3 Euroscreen Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Euroscreen Endometriosis Products Offered
- 11.10.5 Euroscreen Related Developments
- 11.1 AbbVie
- 11.1.1 AbbVie Corporation Information
- 11.1.2 AbbVie Description and Business Overview
- 11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 AbbVie Endometriosis Products Offered
- 11.1.5 AbbVie Related Developments
- 11.12 Kissei Pharmaceutical
- 11.12.1 Kissei Pharmaceutical Corporation Information
- 11.12.2 Kissei Pharmaceutical Description and Business Overview
- 11.12.3 Kissei Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Kissei Pharmaceutical Products Offered
- 11.12.5 Kissei Pharmaceutical Related Developments
- 11.13 Neurocrine Biosciences
- 11.13.1 Neurocrine Biosciences Corporation Information
- 11.13.2 Neurocrine Biosciences Description and Business Overview
- 11.13.3 Neurocrine Biosciences Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Neurocrine Biosciences Products Offered
- 11.13.5 Neurocrine Biosciences Related Developments
- 11.14 Nippon Shinyaku
- 11.14.1 Nippon Shinyaku Corporation Information
- 11.14.2 Nippon Shinyaku Description and Business Overview
- 11.14.3 Nippon Shinyaku Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Nippon Shinyaku Products Offered
- 11.14.5 Nippon Shinyaku Related Developments
- 11.15 Takeda
- 11.15.1 Takeda Corporation Information
- 11.15.2 Takeda Description and Business Overview
- 11.15.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Takeda Products Offered
- 11.15.5 Takeda Related Developments
- 11.16 Bayer AG
- 11.16.1 Bayer AG Corporation Information
- 11.16.2 Bayer AG Description and Business Overview
- 11.16.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Bayer AG Products Offered
- 11.16.5 Bayer AG Related Developments
- 11.17 Neurocrine Biosciences
- 11.17.1 Neurocrine Biosciences Corporation Information
- 11.17.2 Neurocrine Biosciences Description and Business Overview
- 11.17.3 Neurocrine Biosciences Sales, Revenue and Gross Margin (2015-2020)
- 11.17.4 Neurocrine Biosciences Products Offered
- 11.17.5 Neurocrine Biosciences Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Endometriosis Market Estimates and Projections by Region
- 12.1.1 Global Endometriosis Sales Forecast by Regions 2021-2026
- 12.1.2 Global Endometriosis Revenue Forecast by Regions 2021-2026
- 12.2 North America Endometriosis Market Size Forecast (2021-2026)
- 12.2.1 North America: Endometriosis Sales Forecast (2021-2026)
- 12.2.2 North America: Endometriosis Revenue Forecast (2021-2026)
- 12.2.3 North America: Endometriosis Market Size Forecast by Country (2021-2026)
- 12.3 Europe Endometriosis Market Size Forecast (2021-2026)
- 12.3.1 Europe: Endometriosis Sales Forecast (2021-2026)
- 12.3.2 Europe: Endometriosis Revenue Forecast (2021-2026)
- 12.3.3 Europe: Endometriosis Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Endometriosis Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Endometriosis Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Endometriosis Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Endometriosis Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Endometriosis Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Endometriosis Sales Forecast (2021-2026)
- 12.5.2 Latin America: Endometriosis Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Endometriosis Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Endometriosis Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Endometriosis Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Endometriosis Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Endometriosis Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Endometriosis Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Endometriosis Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Endometriosis . Industry analysis & Market Report on Endometriosis is a syndicated market report, published as Global Endometriosis Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Endometriosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
